Clinical Trial Update: Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates adding amifostine to chemotherapy versus chemotherapy alone in patients with recurrent or refractory non-Hodgkin lymphoma or Hodgki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED